DR. OTIS BRAWLEY is the chief medical and scientific officer and executive vice president of the American Cancer Society. Dr. Brawley currently serves as professor of hematology, oncology, medicine and epidemiology at Emory University. He is also a CNN medical consultant. He is a graduate of the University of Chicago, Pritzker School of Medicine, and completed a residency in internal medicine at University Hospitals of Cleveland, Case-Western Reserve University, and a fellowship in medical oncology at the National Cancer Institute.
PAUL GOLDBERG is an award-winning investigative reporter who covers oncology for The Cancer Letter, a weekly publication focused on drug development and the politics of cancer. His articles have appeared in The New York Times, The Wall Street Journal, The Washington Post, The Washington Monthly and he has been featured on 60 Minutes, 20/20, CNN and NPR. Goldberg is also the author of two books on the Soviet human rights movement.
Dr. Otis Brawley is the chief medical and scientific officer and executive vice president of the American Cancer Society. Dr. Brawley currently serves as professor of hematology, oncology, medicine and epidemiology at Emory University. He is also a CNN medical consultant. He is a graduate of the University of Chicago, Pritzker School of Medicine, and completed a residency in internal medicine at University Hospitals of Cleveland, Case-Western Reserve University, and a fellowship in medical oncology at the National Cancer Institute.
Paul Goldberg is the author of the novels
The Yid, which was a finalist for the Sami Rohr Prize for Jewish Literature and the National Jewish Book Award's Goldberg Prize for Debut Fiction, and
The Château. As a reporter, Goldberg has written two books about the Soviet human rights movement, and co-authored (with Otis Brawley) the book
How We Do Harm, an expose of the U.S. healthcare system. His writing has appeared in
The Washington Post, Slate, The New York Times, and elsewhere. He is also the editor and publisher of The Cancer Letter, a publication focused on the business and politics of cancer. He lives in Washington, D.C.
